ArticleNeuro-oncology2022

Radiomics for the noninvasive prediction of the BRAF mutation status in patients with melanoma brain metastases.

Anna-Katharina Meißner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.